Investment in Metaphore Biotechnologies, Inc., which is developing an AI drug discovery platform for functional antibodies
Summary
TOHO Ventures has invested in Metaphore Biotechnologies, a U.S. startup developing an AI-driven platform for functional antibody drug discovery. Metaphore’s MIMIC platform uses large-scale functional data and protein interaction information to design antibodies from biological function rather than only protein structure. The company aims to create agonist and multi-functional antibodies for diseases with significant unmet medical needs. Global Brain said it values the company’s scientific approach, AI capabilities, and experienced leadership team. The investment supports Metaphore’s long-term growth alongside TOHO Holdings.
Funding
Amount
None
Total raised
Date
April 6, 2026
Announcement date
Investors
Flagship Pioneering, Global Brain
Lead investors
Company
metaphorebio.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected